Novel PDGFRB Gene Fusions in Two Cases of Infantile Myofibromatosis
Genes, Chromosomes and Cancer · 2025-01 · 64 (1)
DOI: 10.1002/gcc.70028 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 28.01.2025. Verfasst von Federica Boccia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Myofibromatosis, Receptor, Platelet-Derived Growth Factor beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Infantile myofibromatosis (IM) comprises a wide clinical spectrum, ranging from solitary or multicentric lesions to generalized life‐threatening forms. IM is mostly linked to germline or somatic heterozygous mutations in the PDGFRβ tyrosine kinase, encoded by the PDGFRB gene. Treatments for IM range from wait and see approach to systemic chemotherapy, according to the clinical context. Targeted therapies, such as tyrosine kinase inhibitors (TKIs) like Imatinib, show promise in treating IM lesions with PDGFRB gain‐of‐function mutations. Here, we report the first evidence of two sporadic, multifocal IM with PDGFRB gene fusions. RNA sequencing analysis revealed two novel fusion transcripts involving the protein kinase domain of PDGFRB , with UBE2I and FN1 genes, respectively. Although gene fusions are frequent and potent oncogenic drivers in soft‐tissue neoplasia, fusion genes involving PDGFRB have not previously been linked to IM. DNA‐based NGS panel testing may not detect chromosomal rearrangements, such as translocations, emphasizing the critical role of comprehensive molecular profiling, including RNA sequencing, in diagnosing and managing children with IM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, University of Turin, Turin, Italy.
- Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
- Clinical Pediatrics Genetics Unit, Regina Margherita Children's Hospital, Turin, Italy.
- Pediatric Dermatology Unit, Regina Margherita Children's Hospital, Turin, Italy.
- Otorhinolaryngology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Sabina Barresi, Isabella Giovannoni
Förderung
- Ministero della Salute
Zitieren
APA
Boccia, F., Barresi, S., Vallese, S., Martino, V. D., Bombaci, S., Massuras, S., Gazzin, A., Carli, D., Coppo, P., Roma, R., Giovannoni, I., Mussa, A., & Alaggio, R. (2025). Novel PDGFRB Gene Fusions in Two Cases of Infantile Myofibromatosis. Genes, Chromosomes and Cancer, 64(1). https://doi.org/10.1002/gcc.70028
Vancouver
Boccia F, Barresi S, Vallese S, Martino VD, Bombaci S, Massuras S, et al. Novel PDGFRB Gene Fusions in Two Cases of Infantile Myofibromatosis. Genes, Chromosomes and Cancer. 2025;64(1). doi:10.1002/gcc.70028
BibTeX
@article{Boccia2025,
author = {Boccia, Federica and Barresi, Sabina and Vallese, Silvia and Martino, Valentina Di and Bombaci, Sabrina and Massuras, Stefania and Gazzin, Andrea and Carli, Diana and Coppo, Paola and Roma, Rocco and Giovannoni, Isabella and Mussa, Alessandro and Alaggio, Rita},
title = {Novel PDGFRB Gene Fusions in Two Cases of Infantile Myofibromatosis},
journal = {Genes, Chromosomes and Cancer},
year = {2025},
volume = {64},
number = {1},
doi = {10.1002/gcc.70028}
}
EUVIMED